CEQ501 facts - Freebase.com

Facts from the Community

From the BioVenturist base

Target/Biomolecule of Interest:

Beta-catenin

Indication or disease:

Disease	Phase of development
Familial adenomatous polyposis	Pre-clinical development

Technology involved:

View entire collection »

Developed by:

Cequent Pharmaceuticals

Stage of development:

In development

top ↑

We can tell you that CEQ501 is a…

…Drug
…Medical Treatment

If you know more about CEQ501, you can add more facts here »

These people have edited this topic:

jame0taylor
- Member Since: May 20, 2008
- Contributions: 16,115 Facts

Edit this topic

Last edited Jan 31, 2009 See all topic history »

Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Flag this Topic

Why do you want to flag this topic?

Freebase data is free for use under the CC-BY license.

Learn more about Freebase licensing and attribution

CEQ501